Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportPoster Presentations - Physicians/Scientists/Pharmacists

Re-cyclized octreotide analogues: A structure-activity relationship study

Heather Bigott, Lixin Ma, Fabio Gallazzi, Michael Lewis and Silvia Jurisson
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 511P;
Heather Bigott
1Life Sciences Center, University of Missouri, Columbia, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lixin Ma
2Internal Medicine, University of Missouri, Columbia, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabio Gallazzi
3Molecular Biology Program, University of Missouri, Columbia, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Lewis
4Research, Harry S Truman VA Hospital, University of Missouri, Columbia, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvia Jurisson
5Chemistry, University of Missouri, Columbia, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1866

Objectives: The β turn conformation of the somatostatin (Sst) pharmacophore sequence, Phe-Trp-Lys-Thr, is critical in order to achieve high affinity receptor binding for Sst receptor imaging and radiotherapy agents. Therefore, we determined the three dimensional solution phase structures of several Re-cyclized octreotide analogues by high resolution NMR spectroscopy and correlated our findings with Sst receptor binding affinities.

Methods: We previously reported the synthesis of four Re(V)-cyclized peptides from reduced linear peptides (octreotide, Ac-octreotide, Tyr3-octreotate, and Ac-Tyr3-octreoate) via transchelation reactions with [ReOCl3(OPPh3)(SMe2)] in aqueous methanol solutions (Bigott, et al. J. Labelled Cpd. Radiopharm. 48:S235;2005). For each reaction, the predominant isomer with the expected molecular weight was isolated in pure form by preparative RP-HPLC and confirmed by LCMS. The disulfide-cyclized parent peptides (Re-free) were also synthesized, purified, and confirmed by LCMS. Two dimensional NMR experiments were performed to assess the Re(V) coordination spheres and three dimensional structures of the purified Re(V)-peptides. The parent disulfide peptides were also studied by NMR for comparison with the Re(V)-peptide data. Sst receptor IC50 values were obtained for the Re-peptides and correlated to the NMR structural findings.

Results: In each of the peptides, the ReO metal center was coordinated to the two cysteine sulfurs and the amide nitrogen of the third amino acid in the sequence. The remaining coordination site on the Re metal was filled either by the N-terminal amine nitrogen or, in the case of the N-acetylated peptides, the amide nitrogen of the sixth amino acid. Sst receptor binding affinities were in the 10-7 to 10-8 M range, in a binding order of Ac-octreotide < octreotide < Ac-Tyr3-octrotate < Tyr3-octreotate.

Conclusions: Re-cyclization of these octreotide analogues resulted in low Sst receptor binding affinities, likely due to the perturbation of the β turn relative to the parent disulfide-cyclized peptide structure. Altering the N-terminus of these peptides had a significant effect on the Re(V) coordination sphere, overall peptide structure, and Sst receptor binding affinity. The proximity of the metal center to the β turn in the N-acetylated peptides disrupted the binding to a greater degree than when the N-terminus was involved in metal binding. Further structural modifications to distance the Re binding sphere from the Sst receptor pharmacophore may lead to new radiopharmaceutical agents with enhanced receptor binding.

  • Society of Nuclear Medicine, Inc.
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 47, Issue suppl 1
May 1, 2006
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Re-cyclized octreotide analogues: A structure-activity relationship study
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Re-cyclized octreotide analogues: A structure-activity relationship study
Heather Bigott, Lixin Ma, Fabio Gallazzi, Michael Lewis, Silvia Jurisson
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 511P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Re-cyclized octreotide analogues: A structure-activity relationship study
Heather Bigott, Lixin Ma, Fabio Gallazzi, Michael Lewis, Silvia Jurisson
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 511P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Poster Presentations - Physicians/Scientists/Pharmacists

  • Selective internal radiotherapy (SIRT) of liver metastases and hepatocellular carcinoma: Is the posttherapeutic distribution of SIR Spheres® related to the pretherapeutic deposition of MAA in FDG positive lesions?
  • Mononuclear Tc-99m-chelate-conjugated oligo-aspartic acid as a new bone imaging agent
  • Tritium labeled choline and fluoroethylcholine – In vitro evaluation for visualization of prostate cancer with PET
Show more Poster Presentations - Physicians/Scientists/Pharmacists

Radiopharmaceutical Chemistry Track

  • Preparation of high specific activity Fluorine-18 nanoparticles using click chemistry
  • Radionuclide impurities of 210Po produced by neutron irradiation of 209Bi for use in targeted alpha-particle radiotherapy
  • Styrylbenzoxazole derivatives for beta-amyloid plaque imaging
Show more Radiopharmaceutical Chemistry Track

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire